TriangleNCT03440411 · OUTCOME
Progression Free Survival 2(PFS2)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 57 months
What was measured
PFS for the comparison II vs I will be measured from the date of randomization disclosure to the date of first observation of PD in second line therapy, or death from any cause as an event. Subjects who have not progressed or who withdraw from the study will be censored at the time of the last complete disease assessment. All subjects who were lost to FU will also be censored at the time of last complete disease assessment
Analysis population: This analysis included only patients in whom CPd vs Pd randomization was disclosed.
Groups in this outcome
Arm I
Early Treatment
Arm II
Late treatment
| Group | Source count |
|---|---|
| Arm I | 5 |
| Arm II | 3 |
Reported measurements
Source class 1
Events
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I | 2 | Not reported | Not reported | Not reported | Not reported |
| Arm II | 1 | Not reported | Not reported | Not reported | Not reported |
Censored
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I | 3 | Not reported | Not reported | Not reported | Not reported |
| Arm II | 2 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 1
- title
- Events
- measurements
- group Id
- OG000
- value
- 3
- group Id
- OG001
- value
- 2
- title
- Censored
- denoms
- counts
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 3
- units
- Participants
- description
- PFS for the comparison II vs I will be measured from the date of randomization disclosure to the date of first observation of PD in second line therapy, or death from any cause as an event. Subjects who have not progressed or who withdraw from the study will be censored at the time of the last complete disease assessment. All subjects who were lost to FU will also be censored at the time of last complete disease assessment
- groups
- description
- Early Treatment
- id
- OG000
- title
- Arm I
- description
- Late treatment
- id
- OG001
- title
- Arm II
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- This analysis included only patients in whom CPd vs Pd randomization was disclosed.
- reporting Status
- POSTED
- time Frame
- 57 months
- title
- Progression Free Survival 2(PFS2)
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice